🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Caplet(s) Serving Size
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

1000 mg
📊 Market median: 500.0mg (159 products)
Median 500.0mg This product: 1000mg

Other Ingredients

Vegetable Cellulose Stearic Acid Vegetable Magnesium Stearate Silica Vegetable Glaze

Label Claims — Verification

Nutrient
All Other
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Kosher Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one caplet daily or as directed by a healthcare practitioner.

🧪 Formulation Notes

Bluebonnet’s L-Lysine 1000 mg Caplets contain the pharmaceutical grade, free-form amino acid L-lysine HCl in its purest crystalline form from Ajinomoto.

Made with non-GMO ingredients

Vegan

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of corn, yeast, gluten, barley, rice, sodium and sugar.

Bluebonnet’s KOF-K Certification #K-0000700

Additional Information

Available in easy-to-swallow caplets for maximum assimilation and absorption.

0056D

Made with non-GMO ingredients

Free-form amino acid

Vegan

K Parve

Gluten free

Product Details

UPC / SKU 7 43715 00056 8
DSLD Entry Date 2018-05-24
Product Type Amino acid/Protein
Form Other (e.g. tea bag)
Brand Bluebonnet
DSLD ID 176489
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →